The following related clinical trials and research studies are currently seeking participants at Massachusetts General Hospital. Search for clinical trials and studies in another area of interest.
MGH Hotline 5.08.09 Approximately 100 people attended the Friends of the MGH Cancer Center’s annual fundraising forum April 22 in the Bulfinch Tents. This year’s event featured MGH skin cancer experts David Fisher, MD, PhD, chief of the Department of Dermatology and director of the Center for Melanoma, left, and Jennifer Wargo, MD, of the Department of Surgery.
Hensin Tsao, MD, Director of Mass General's Melanoma and Pigmented Lesion Center explains how family history, genetic risks and personal health history can all affect your risk of melanoma, and what steps you should take to detect it at an early, treatable stage.
John Murphy has an amazing story to tell. Listen to his story and learn about advances in targeted cancer therapies that are bringing new hope to patients. With the opening of the Henri and Belinda Termeer Center for Targeted Therapies, the Mass General Cancer Center is expanding its phase one clinical trials program to help more patients like him.
Dr. Keith Flaherty is the director of the Henri and Belinda Termeer Center for Targeted Therapies. Dr. Flaherty and his exceptional team of clinicians and scientists are spearheading research into promising new treatment options for patients through phase I clinical investigation.